Ebola vaccine works – New monkey scientific tests indicate that one chance of the experimental Ebola vaccine can trigger quickly safeguard. Some healthy people are rolling up their sleeves at the National Institutes of Health for the first human safety study of this vaccine in hopes it eventually might be used in the current Ebola outbreak in West Africa.
The NIH on Sunday published some of the key animal research behind those injections. One reason the vaccine was deemed promising was that a single dose protected all four vaccinated monkeys when they were exposed to high levels of Ebola virus just five weeks later, researchers reported in the journal Nature Medicine.
However the result decreased unless of course the animals obtained a booster-style chance made an alternative approach.